-
Health News Roundup: WHO warns of falsified cough syrup ingredients seized in Pakistan; Novavax investor Shah Capital pushes for board shakeup and more
15 Apr 2024 21:05 GMT
… ;s life is in danger.
Novavax investor Shah Capital pushes for … of COVID-19 vaccine maker Novavax on Monday said the company … two candidates to serve on Novavax's board. Shah Capital … a high risk of diseases developing that could jump from animals …
-
COVID-19 Not Associated With Increased Risk of Asthma Development in Children
15 Apr 2024 19:00 GMT
… the risk of asthma development in pediatric patients, according … s impact on asthma development in children. Limitations include … critical factor.”
READ MORE: Novavax COVID-19 Vaccine Shows … know contribute to asthma development and provides clinically useful …
-
Novavax comes under pressure from activist investor as COVID sales fall short
15 Apr 2024 16:26 GMT
… of Novavax's stock, has claimed that the vaccine developer … identified as value destroyers for Novavax,” the Shah letter reads. … dubbed Spikevax.
Shah pressed Novavax to immediately adopt a more … , a trend that prompted Novavax to implement cost cuts, …
-
Shah Capital nominates two highly qualified independent director candidates for Novavax
15 Apr 2024 10:00 GMT
… realize shareholder value reflective of Novavax’s significant competitive advantages and … “Possessing interests aligned with all Novavax shareholders, Shah Capital is invested … in management consulting and product development and served in global leadership …
-
Better Buy: Bluebird Bio Vs. Novavax
13 Apr 2024 21:40 GMT
… soar.
The case for Novavax
Novavax is also a pretty innovative … sea of biotechs seeking to develop effective COVID-19 medicines, … million and $1 billion.
Novavax is developing one other product. It … has proven it can develop innovative therapies in an area …
-
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
12 Apr 2024 11:07 GMT
… but is it enough?
Novavax previously issued a going concern … existing shareholders.
This year, Novavax projects its revenue will fall … is also projecting research and development and selling, general, and … still get worse for Novavax.
David Jagielski has no …
-
Vaccine in Development Could Offer Better Flu Protection
11 Apr 2024 12:25 GMT
…
Recombinant protein vaccines, like the Novavax vaccine used to fight COVID … , there is much interest in developing recombinant influenza vaccines. To date … vaccine the research team is developing is based on a nanoliposome …
-
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
01 Apr 2024 19:00 GMT
… of developing broadly protective antigens or combination vaccines.
Novavax presentations … functions
between mRNA and
Novavax protein-based
COVID Vaccination
… About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and …
-
Vaccines in Development
28 Mar 2024 17:53 GMT
… adjuvant, which was developed by Novavax and is made … Technologies Used for Vaccine Development. [Golgher and Rodrigues] … against visceral leishmaniasis, developed by Gazzinelli and his … ImunoTera is dedicated to developing immunotherapies against infectious …
-
Novavax COVID-19 Vaccine Shows Lasting Protection Against Delta Variant
19 Mar 2024 23:22 GMT
… -19 vaccine from biotechnology company Novavax demonstrated durable protection against the …
ClinicalTrials.gov Identifier: NCT04611802
Sponsor: Novavax
Summary: This is a phase … a third dose (first booster).
“Development of durable and broadly protective …